184 related articles for article (PubMed ID: 27922588)
21. Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
Park IR; Moon JS
Diabetes Metab J; 2024 May; 48(3):387-389. PubMed ID: 38802118
[No Abstract] [Full Text] [Related]
22. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
Gotto AM; Farmer JA
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
[TBL] [Abstract][Full Text] [Related]
23. Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using data registries.
Ara R; Pandor A; Tumur I; Paisley S; Duenas A; Williams R; Wilkinson A; Durrington P; Chilcott J
Clin Ther; 2008 Aug; 30(8):1508-23. PubMed ID: 18803993
[TBL] [Abstract][Full Text] [Related]
24. Ezetimibe: rescued by randomization (clinical and mendelian).
McPherson R; Hegele RA
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):e13-5. PubMed ID: 25550209
[No Abstract] [Full Text] [Related]
25. [Ezetimibe in clinical practice: from laboratory investigations to the IMPROVE-IT trial results].
Borghi C; Filardi PP
G Ital Cardiol (Rome); 2015; 16(7-8 Suppl 1):3S-14S. PubMed ID: 26442834
[TBL] [Abstract][Full Text] [Related]
26. The comparative impact among different intensive statins and combination therapies with niacin/ezetimibe on carotid intima-media thickness: a systematic review, traditional meta-analysis, and network meta-analysis of randomized controlled trials.
Li H; Xu X; Lu L; Sun R; Guo Q; Chen Q; Wang J; He Z; Zhang Y
Eur J Clin Pharmacol; 2021 Aug; 77(8):1133-1145. PubMed ID: 33604752
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial.
Cannon CP; Cariou B; Blom D; McKenney JM; Lorenzato C; Pordy R; Chaudhari U; Colhoun HM;
Eur Heart J; 2015 May; 36(19):1186-94. PubMed ID: 25687353
[TBL] [Abstract][Full Text] [Related]
28. Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients.
Descamps O; Tomassini JE; Lin J; Polis AB; Shah A; Brudi P; Hanson ME; Tershakovec AM
Atherosclerosis; 2015 Jun; 240(2):482-9. PubMed ID: 25913444
[TBL] [Abstract][Full Text] [Related]
29. Ezetimibe: a novel option for lowering cholesterol.
Davidson MH
Expert Rev Cardiovasc Ther; 2003 May; 1(1):11-21. PubMed ID: 15030293
[TBL] [Abstract][Full Text] [Related]
30. Lack of accurate evidence on non-statin medication in patients receiving highintensity statin therapy: Re-evaluation of recommendations is needed.
Demirci D; Ersan Demirci D
Anatol J Cardiol; 2018 Mar; 19(3):230. PubMed ID: 29521324
[No Abstract] [Full Text] [Related]
31. [Ezetimibe (Ezetrol)].
Scheen AJ
Rev Med Liege; 2004 Apr; 59(4):246-50. PubMed ID: 15182038
[TBL] [Abstract][Full Text] [Related]
32. Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study.
Miyoshi T; Nakamura K; Doi M; Ito H
Am J Cardiovasc Drugs; 2015 Jun; 15(3):213-9. PubMed ID: 25896669
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of a combination of ezetimibe and statins in patients with acute coronary syndrome and multiple comorbidities: A 6-year population-based cohort study.
Lin Wu FL; Wang J; Ho W; Chou CH; Wu YJ; Choo DW; Wang YW; Chen PY; Chien KL; Lin ZF
Int J Cardiol; 2017 Apr; 233():43-51. PubMed ID: 28190615
[TBL] [Abstract][Full Text] [Related]
34. Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study.
Punekar RS; Fox KM; Paoli CJ; Richhariya A; Cziraky MJ; Gandra SR; Toth PP
Curr Med Res Opin; 2017 May; 33(5):869-876. PubMed ID: 28276256
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
[TBL] [Abstract][Full Text] [Related]
36. Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia.
Toth PP; Catapano AL; Farnier M; Foody J; Tomassini JE; Jensen E; Polis AB; Hanson ME; Musliner TA; Tershakovec AM
Am J Cardiol; 2016 Dec; 118(12):1812-1820. PubMed ID: 27756478
[TBL] [Abstract][Full Text] [Related]
37. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
Hou R; Goldberg AC
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
[TBL] [Abstract][Full Text] [Related]
38. [Importance of dyslipidaemia in cardiovascular disease: a point of view].
Ascaso JF; Carmena R
Clin Investig Arterioscler; 2015; 27(6):301-8. PubMed ID: 26363575
[TBL] [Abstract][Full Text] [Related]
39. Are perioperative statins beneficial for cardiac surgery?
Bravo-Soto GA; Llovet-Gutiérrez V; Rada G
Medwave; 2017 Jan; 17(Suppl1):e6834. PubMed ID: 28112708
[TBL] [Abstract][Full Text] [Related]
40. Impact of ezetimibe coadministered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective cohort study in Taiwan.
Lin CF; Gau CS; Wu FL; Hsiao FY; Bai CH; Shen LJ
Clin Ther; 2011 Sep; 33(9):1120-31. PubMed ID: 21872930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
